← ANALYST RATINGS · TIPRANKS
Neogen (NEOG): analyst forecast and price target
Analyst consensus
Moderate Buy2 Buy1 Hold0 Sell
Ratings of 3 analysts in the last 3 months12-month forecast
Based on 3 price targets given in the last 3 months, the average target is $14.00, the highest $14.00, the lowest $14.00. The average is +18.5% from the last price of $11.81.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| AI Google Medical - DevicesGemini 2.5Pro | TipRanks - Google | $13.50 → $13.00−3.7% | Hold | +10.1% | Reiterated | 07.10.26on TipRanks 13:05 | — | |
| AI xAi Medical - DevicesxAI Grok-3 | TipRanks - xAI | $13.50 → $12.50−7.4% | Hold | +5.8% | Reiterated | 07.10.26on TipRanks 12:06 | — | |
| AI DeepSeek Medical - DevicesDeepSeek R1-0528 | TipRanks - DeepSeek | $13.50 → $12.50−7.4% | Hold | +5.8% | Reiterated | 07.10.26on TipRanks 12:06 | — | |
| AI OpenAI Medical - DevicesOpenAI 4o | TipRanks - OpenAI | $13.00 → $12.50−3.8% | Hold | +5.8% | Reiterated | 07.10.26on TipRanks 10:06 | — | |
| AI Anthropic Medical - DevicesAnthropic Opus-4.1 | TipRanks - Anthropic | $13.00 → $12.00−7.7% | Hold | +1.6% | Reiterated | 07.10.26on TipRanks 10:06 | — | |
| AI PerPlexity Medical - DevicesPerPlexity SonarPro | TipRanks - PerPlexity | $13.50 → $13.00−3.7% | Hold | +10.1% | Reiterated | 07.10.26on TipRanks 10:06 | — | |
| David Westenberg★★★★★★★★★★#602 · hits 56% · avg +17.3% | Piper Sandler | $14.00 | Buy | +18.5% | Reiterated | 07.10.26on TipRanks 07:26 | −2.1%next day +0.7% · 5 days +4.8% | ↗ |
| Subbu Nambi★★★★★★★★★★#281 · hits 72% · avg +34.4% | Guggenheim | $12.00 → $14.00+16.7% | Buy | +18.5% | Reiterated | 29.09.26on TipRanks 13:21 | −7.0%next day +0.8% · 5 days −8.0% | ↗ |
| Brandon Vazquez★★★★★★★★★★#11688 · hits 42% · avg −5.1% | William Blair | — | Hold | — | Reiterated | 28.09.26on TipRanks 06:06 | +0.5%next day −7.0% · 5 days −6.4% | ↗ |
| Robert Labick★★★★★★★★★★#4814 · hits 71% · avg +20.5% | CJS Securities | $10.00 | Buy | −15.3% | Upgrade | 10.12.25on TipRanks Dec 11 01:45 | +8.4%next day +0.6% · 5 days +3.9% | ↗ |
| No ratings for this filter. | ||||||||
The latest rating of each analyst in the last 12 months, as TipRanks lists them. Every rating kept, earlier ones included
Best analysts covering Neogen
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
How the average price target moved
The average target of all analysts (their ratings of the 3 months before) on each day, the top analysts’ dashed, against the price; the site keeps this record since 1 October 2026. On 01.10.26: target $14.00 at a price of $12.80 (+9.4%); now: $14.00 at $11.81 (+18.5%).
PriceAverage targetTop analysts’ target
Recommendation trend
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 1 | 2 | 4 | 4 |
| Hold | 2 | 2 | 3 | 4 | 5 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Earnings and sales forecast
Next report: 14.01.27 (Q2 2027, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $0.08 (from $0.06 to $0.10). Last quarter: $0.08.
Sales
Next quarter’s sales estimate — $225M (from $223M to $229M). Last quarter: $223M.
Best top-analyst consensus in the sector · Healthcare
About Neogen
- CEO: Mikhael Nassif
- Employees: 2,636
- 620 Lesher Place, Lansing, MI, 48912-1595, US
- www.neogen.com
Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in
Data from the stock’s TipRanks forecast page, read 22 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗